Stephen Bruso

Stephen Bruso is an experienced venture capital professional and board member with a focus on investments in the biopharma and digital health sectors. He currently serves as a Board Member at PsycApps Digital Mental Health Games, a position he has held since August 2022.1

Professional Background

Stephen Bruso joined Morningside Technology Advisory LLC in February 2019, where he works in venture capital in the Greater Boston Area.1 At Morningside, he focuses on investments in both biopharma and digital health fields.2

Board Positions

In addition to his role at PsycApps, Bruso holds board positions at several other companies, including:

• Curve Health (since June 2022)
• Koa Health (since May 2022)
• SimpliFed (since May 2022)
• Wellinks (since October 2021)
• ieso (since October 2021)
• Huckleberry Labs (since September 2021)
• MedRhythms, Inc. (since July 2021)
• DeepCure (since June 2021)
• Innodem Neurosciences (since January 2021)
• Neuroelectrics (since November 2020)
• Curai (since September 2020)
• Vesigen Therapeutics, Inc. (since July 2020)
• Cognito Therapeutics, Inc. (since January 2020)12

He also serves as a Board Observer at Linus Health since September 2020.12

Education

Bruso holds an MBA from Boston University Questrom School of Business, which he completed in 2019, graduating magna cum laude.2 He also received a BA from Emory University in 2009.12

Language Skills

Stephen Bruso is proficient in multiple languages:

• English (native or bilingual proficiency)
• Chinese (native or bilingual proficiency)
• Spanish (limited working proficiency)1

His diverse board positions and language skills indicate a broad range of expertise in the health technology sector, particularly in digital mental health solutions like PsycApps.